Microcapsule Semi-Permeable Shell for Single-Cell Lysis and Nucleic Acid Isolation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for single-cell PCR and RT-PCR face challenges such as complex microfluidic workflows, cell and nucleic acid loss, reduced sensitivity, and inhibition of nucleic acid amplification due to harsh lysis conditions.

Innovation Solution

The development of microcapsules with a semi-permeable shell and a core containing antichaotropic agents and polyhydroxy compounds, which allow for efficient cell encapsulation, lysis, and nucleic acid analysis without the need for sophisticated microfluidic systems.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If harsh lysis reagents (SDS, guanidinium thiocyanate) are used to efficiently lyse encapsulated cells, then cell lysis efficiency is improved, but nucleic acid amplification is inhibited

Engineering Contradiction:
Improvecell lysis efficiencyVSAvoidnucleic acid amplification inhibition
Core Design Contradiction:
ProductivityVSObject-generated harmful factors

Solution Approach 1:

The reaction process is divided into two separate compartments: a first compartment for cell lysis and a second compartment for nucleic acid amplification. This segmentation allows harsh lysis reagents to be used in the first compartment without inhibiting the amplification reaction in the second compartment, as the reagents are physically separated by the semi-permeable membrane.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

A semi-permeable membrane acts as an intermediary between the lysis compartment and the amplification compartment. This membrane allows small molecules and nucleic acids to pass through while retaining larger cellular components and lysis reagents, thereby mediating the transfer of nucleic acids from the lysis compartment to the amplification compartment while preventing inhibition.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If mild lysis conditions with non-ionic detergents are used to maintain compatibility with polymerase enzymes, then nucleic acid amplification compatibility is improved, but cell lysis efficiency is reduced

Engineering Contradiction:
Improvenucleic acid amplification compatibilityVSAvoidcell lysis efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The reaction process is divided into two separate compartments: a first compartment for cell lysis and a second compartment for nucleic acid amplification. This segmentation allows harsh lysis reagents to be used in the first compartment without inhibiting the amplification reaction in the second compartment, as the reagents are physically separated by the semi-permeable membrane.

Inventive Principle:
Principle #1Segmentation

3Adaptability or versatility

If complex microfluidic workflows are used to perform multi-step reactions with reagent replacement, then reaction control is improved, but device complexity increases

Engineering Contradiction:
Improvereaction controlVSAvoidmicrofluidic workflow complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The reaction process is divided into two separate compartments: a first compartment for cell lysis and a second compartment for nucleic acid amplification. This segmentation allows harsh lysis reagents to be used in the first compartment without inhibiting the amplification reaction in the second compartment, as the reagents are physically separated by the semi-permeable membrane.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The semi-permeable membrane enables automatic exchange of reagents and products between compartments based on concentration gradients and molecular size, reducing the need for complex external control mechanisms. Small molecules and nucleic acids automatically diffuse through the membrane while larger components are retained, providing self-regulating reaction control.

Inventive Principle:
Principle #25Self-service

4Object-generated harmful factors

If droplet splitting and fusion operations are performed to dilute cell lysate, then inhibition is reduced, but workflow complexity and reagent loss increase

Engineering Contradiction:
Improvelysate-mediated inhibitionVSAvoidmicrofluidic operation complexity
Core Design Contradiction:
Object-generated harmful factorsVSDevice complexity

Solution Approach 1:

A semi-permeable membrane acts as an intermediary between the lysis compartment and the amplification compartment. This membrane allows small molecules and nucleic acids to pass through while retaining larger cellular components and lysis reagents, thereby mediating the transfer of nucleic acids from the lysis compartment to the amplification compartment while preventing inhibition.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The microcapsules enable efficient retention of biological entities, improved cell lysis efficiency, and effective removal of inhibitors, allowing for high-sensitivity nucleic acid assays and easy handling of large numbers of cells in a massively parallel fashion.

Implementation Method 1

a semi-permeable shell surrounding the core

Methodology Applied
Scientific EffectSemipermeable membrane: Semipermeable Membrane

Implementation Method 2

the semi-permeable shell comprising a gel formed from a polyampholyte

Methodology Applied
Scientific EffectGel: Gel

Implementation Method 3

wherein the polyampholyte in the gel is covalently cross-linked

Methodology Applied
Scientific EffectCovalent bonding: Chemical Bonding

Implementation Method 4

the core comprising an antichaotropic agent and/or a polyhydroxy compound

Methodology Applied
Scientific EffectSolvation: Solvation

Data Source

PatentUS20250129418A1Microcapsules comprising biological samples, and methods for use of same
Publication Date: 2025.04.24 VILNIUS UNIV
  • US20250129418A1 patent drawing
  • US20250129418A1 patent drawing
  • US20250129418A1 patent drawing

AI summary

The present invention concerns a method of performing one or more reactions on a biological entity, the method comprising: (i) isolating the biological entity in a microcapsule comprising a core and a semi-permeable shell; and (ii) performing the one or more reactions on the biological entity in the microcapsule.